Hyaluronic acid in the pleural fluid of patients with malignant pleural mesothelioma

Respiratory Investigation

Volumn 51, Issue 2, 2013, Pages 92-97

  Fujimoto, Nobukazu ^a,b   Gemba, Kenichi ^a   Asano, Michiko ^a   Fuchimoto, Yasuko ^a   Wada, Sae ^a   Ono, Katsuichiro ^a   Ozaki, Shinji ^a   Kishimoto, Takumi ^a  

^a OKAYAMA ROSAI HOSPITAL   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION FUKUYAMA MEDICAL CENTER   (Japan)

Author keywords

Asbestos; Hyaluronic acid; Mesothelioma; Pleural fluid

Indexed keywords

HYALURONIC ACID;

AREA UNDER THE CURVE; ARTICLE; CANCER STAGING; COLLAGEN DISEASE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; LUNG CANCER; LUNG INFECTION; MAJOR CLINICAL STUDY; PLEURA FLUID; PLEURA MESOTHELIOMA; PLEURISY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYALURONIC ACID; LUNG NEOPLASMS; MESOTHELIOMA; PLEURAL EFFUSION; PLEURAL NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84879258828     PISSN: 22125345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resinv.2013.02.002     Document Type: Article

References (27)

1. Gemba K, Fujimoto N, Aoe K., et al. Treatment and survival analyses of malignant mesothelioma in Japan. Acta Oncol; in press (posted online on August 29, 2012, ). doi:10.3109/0284186X.2012.709948.
2. Robinson B.W., Lake R.A. Advances in malignant mesothelioma. N Engl J Med 2005, 353:1591-1603.
3. Fujimoto N., Aoe K., Gemba K., et al. Clinical investigation of malignant mesothelioma in Japan. J Cancer Res Clin Oncol 2010, 136:1755-1759.
4. Shi H.Z., Liang Q.L., Jiang J., et al. Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis. Respirology 2008, 13:518-527.
5. Liang Q.L., Shi H.Z., Qin X.J., et al. Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis. Thorax 2008, 63:35-41.
6. Aoe K., Hiraki A., Maeda T., et al. Soluble receptor-binding cancer antigen expressed on SiSo cells in pleural fluid: a potential diagnostic marker for malignant pleural effusion. Chest 2004, 126:1195-1197.
7. Scherpereel A., Grigoriu B., Conti M., et al. Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma. Am J Respir Crit Care Med 2006, 173:1155-1160.
8. Fujimoto N., Gemba K., Asano M., et al. Soluble mesothelin-related protein in pleural effusion from patients with malignant pleural mesothelioma. Exp Ther Med 2010, 1:313-317.
9. Shiomi K., Hagiwara Y., Sonoue K., et al. Sensitive and specific new enzyme-linked immunosorbent assay for N-ERC/mesothelin increases its potential as a useful serum tumor marker for mesothelioma. Clin Cancer Res 2008, 14:1431-1437.
10. Fujii M., Fujimoto N., Hiraki A., et al. Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesothelioma. Cancer Sci 2012, 103:510-514.
11. Laurent T.C., Fraser J.R. Hyaluronan. FASEB J 1992, 6:2397-2404.
12. Toole B.P. Hyaluronan promotes the malignant phenotype. Glycobiology 2002, 12:37R-42R.
13. Meyer K.C.E. Hyaluronic acid in pleural fluid associated with malignant tumour involving pleura and peritoneum. Proc Soc Exp Biol Med 1939, 42:4.
14. Arai H., Endo M., Sasai Y., et al. Histochemical demonstration of hyaluronic acid in a case of pleural mesothelioma. Am Rev Respir Dis 1975, 111:699-702.
15. Arai H., Kang K.Y., Sato H., et al. Significance of the quantification and demonstration of hyaluronic acid in tissue specimens for the diagnosis of pleural mesothelioma. Am Rev Respir Dis 1979, 120:529-532.
16. Wagner J.C., Munday D.E., Harington J.S. Histochemical demonstration of hyaluronic acid in pleural mesotheliomas. J Pathol Bacteriol 1962, 84:73-78.
17. Roboz J., Greaves J., Silides D., et al. Hyaluronic acid content of effusions as a diagnostic aid for malignant mesothelioma. Cancer Res 1985, 45:1850-1854.
18. Frebourg T., Lerebours G., Delpech B., et al. Serum hyaluronate in malignant pleural mesothelioma. Cancer 1987, 59:2104-2107.
19. Pettersson T., Froseth B., Riska H., et al. Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma. Chest 1988, 94:1037-1039.
20. Martensson G., Thylen A., Lindquist U., et al. The sensitivity of hyaluronan analysis of pleural fluid from patients with malignant mesothelioma and a comparison of different methods. Cancer 1994, 73:1406-1410.
21. Rusch V.W. A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group. Lung Cancer 1996, 14:1-12.
22. 1999, World Health Organization, Geneva. 3rd ed.
23. Soderblom T., Pettersson T., Nyberg P., et al. High pleural fluid hyaluronan concentrations in rheumatoid arthritis. Eur Respir J 1999, 13:519-522.
24. Hillerdal G., Lindqvist U., Engstrom-Laurent A. Hyaluronan in pleural effusions and in serum. Cancer 1991, 67:2410-2414.
25. Eisenstadt H.B. Asbestos pleurisy. Dis Chest 1964, 46:78-81.
26. Epler G.R., McLoud T.C., Gaensler E.A. Prevalence and incidence of benign asbestos pleural effusion in a working population. J Am Med Assoc 1982, 247:617-622.
27. Asplund T., Versnel M.A., Laurent T.C., et al. Human mesothelioma cells produce factors that stimulate the production of hyaluronan by mesothelial cells and fibroblasts. Cancer Res 1993, 53:388-392.